Target intelligence / Profile preview

Actin, cytoplasmic 1 (ACTB)

Target
ACTB
Molecular classification
Cytoskeletal protein, Structural protein, Actin family, Other
01

Overview

Actin, cytoplasmic 1 (encoded by the ACTB gene, commonly known as β-actin), is a highly conserved, abundant structural protein ubiquitously expressed in all eukaryotic cells[1][4][6][7]. It dynamically assembles into filaments (F-actin) and exists in a monomeric form (G-actin), forming the core of the cytoskeleton and participating in various essential cellular processes including maintenance of cell shape, cell motility, cell division (cytokinesis), chromatin remodeling, and regulation of gene expression[1][2][4][5][8]. Actin filaments interact with numerous actin-binding proteins, affecting key cellular activities and acting as hubs for complex intracellular signaling and structure[2][3][4]. Mutations in ACTB can cause human disease, including developmental syndromes and have secondary roles in cancer cell biology[8]. Actin is not typically considered a classical therapeutic target due to its essential and conserved functions, but it is extensively used as a cellular marker and research tool[1][4]. Several toxins and research drugs bind actin, interfering with filament dynamics (e.g., cytochalasin D, phalloidin), but their clinical utility is limited by toxicity and a lack of cell-type specificity[4].

Other names
Beta-actinCytoplasmic actin 1ACTB
02

Mechanism of action

Polymerization inhibition or stabilization (for actin inhibitors/stabilizers); Disruption of actin filaments influencing cell motility, morphology, and division

03

Biological functions

Maintenance of cell shapeCell motilityMuscle contraction (as part of general actin function)CytokinesisChromatin remodelingTranscriptional regulationDNA repairSignal transduction integration
04

Disease associations

CancerNeurodevelopmental disorders (due to ACTB mutations)Other (implicated in cell proliferation abnormalities)
05

Safety considerations

Actin is essential for cell viability; direct inhibition in humans is generally cytotoxicHigh conservation and ubiquitous expression make selective targeting very difficult
06

Interacting drugs

Cytochalasin D

3 more in the full profile.

07

Biomarkers

Housekeeping gene marker (β-actin used as internal control in expression studies)Rarely as a disease marker (mutant ACTB alleles in some syndromes)

Beyond the preview

Go deeper on Actin, cytoplasmic 1 (ACTB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin, cytoplasmic 1 (ACTB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call